The 2026 AHA/ASA guidelines for acute ischemic stroke introduce significant updates and first-ever pediatric stroke recommendations.
American Heart Association consortium advances development of evidence-based health tech solutions: announcement comes as new ...
The guidelines for care of patients that have experienced acute ischemic stroke have been updated by the American Stroke Association.
The "golden window" for treatment was strictly limited to 4.5 hours. However, the 2026 guidelines introduce a more flexible approach based on advanced imaging.
Findings from the ASA International Stroke Conference show tenecteplase 4.5 to 24 hours after onset improves 90-day functional outcomes.
Global phase 3 OCEANIC-STROKE randomized 12,327 patients to asundexian 50 mg daily vs placebo on background antiplatelets, with follow-up to 31 months. Treatment effects were consistent across TOAST ...
Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results